Alteration of Glucose Homeostasis in V1a Vasopressin Receptor-Deficient Mice
The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Arginine-vasopressin (AVP) is known to be involved in maintaining glucose homeostasis, and AVP-resistance is observed in poorly controlled non-insulin-dependent diabetes mellitus subjects, resulting in a lowered plasma volume. Recently we reported that V1a vasopressin receptor-deficient (V1aR−/−) mice exhibited a decreased circulating blood volume and hypermetabolism of fat accompanied with impaired insulin-signaling. Here we further investigated the roles of the AVP/V1a receptor in regulating glucose homeostasis and plasma volume using V1aR−/− mice. The plasma glucose levels at the baseline or during a glucose tolerance test were higher in V1aR−/− than wild-type (WT) mice. Moreover, a hyperinsulinemic-euglycemic clamp revealed that the glucose infusion rate was significantly lower in V1aR−/− mice than in WT mice and that hepatic glucose production was higher in V1aR−/− mice than WT mice. In contrast to the increased hepatic glucose production, the liver glycogen content was decreased in the mutant mice. These results indicated that the mutant mice had impaired glucose tolerance. Furthermore, feeding V1aR−/− mice a high-fat diet accompanied by increased calorie intake resulted in significantly overt obesity in comparison with WT mice. In addition, we found that the circulating plasma volume and aldosterone level were decreased in V1aR−/− mice, although the plasma AVP level was increased. These results suggested that the effect of AVP on water recruitment was disturbed in V1aR−/− mice. Thus, we demonstrated that one of the AVP-resistance conditions resulting from deficiency of the V1a receptor leads to decreased plasma volume as well as impaired glucose homeostasis, which can progress to obesity under conditions of increased calorie intake.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mice lacking the V1aR display impaired glucose tolerance, insulin resistance and elevated AVP levels20”
From Plasma Copeptin and the Risk of Diabetes Mellitus (2010) · cites this paper as [20]
In the citing paper
“The finding that mice with deleted V1aR and/or V1bR exhibit metabolic disorders [12][13][14][15] has prompted several epidemiological investigations in humans.”
From Vasopressin and hydration play a major role in the development of glucose intolerance and hepatic steatosis in obese rats (2015) · cites this paper as [12]
Citations
Cites
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
Serum Immunoreactive-Leptin Concentrations in Normal-Weight and Obese Humans
Considine, R. V., Sinha, M. K., Heiman, M. L., Kriauciunas, A., Stephens, T. W., Nyce, M. R., Ohannesian, J. P., Marco, C. C., McKee, L. J., Bauer, T. L., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602013340503 · Cited by 6,326
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) · Diabetes Care · doi:10.2337/diacare.26.2007.s5 · Cited by 2,689
Frederich, R. C., Hamann, A., Anderson, S., Löllmann, B., Lowell, B. B., & Flier, J. S. (1995) · Nature Medicine · doi:10.1038/nm1295-1311 · Cited by 1,660
Atrial natriuretic factor—a circulating hormone stimulated by volume loading
Lang, R. E., Thölken, H., Ganten, D., Luft, F. C., Ruskoaho, H., & Unger, T. (1985) · Nature · doi:10.1038/314264a0 · Cited by 1,230
Impact of Obesity on Plasma Natriuretic Peptide Levels
Wang, T. J., Larson, M. G., Levy, D., Benjamin, E. J., Leip, E. P., Wilson, P. W. F., & Vasan, R. S. (2004) · Circulation · doi:10.1161/01.cir.0000112582.16683.ea · Cited by 1,022
Natriuretic peptides: a new lipolytic pathway in human adipocytes
Sengenès, C., Berlan, M., de Glisezinski, I., Lafontan, M., & Galitzky, J. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.10.1345 · Cited by 532
Lolait, S. J., O'Carroll, A.-M., McBride, O. W., Konig, M., Morel, A., & Brownstein, M. J. (1992) · Nature · doi:10.1038/357336a0 · Cited by 524
Molecular cloning and expression of a rat Via arginine vasopressin receptor
Morel, A., O'Carroll, A.-M., Brownstein, M. J., & Lolaft, S. J. (1992) · Nature · doi:10.1038/356523a0 · Cited by 477
Glucose Inhibition of the Glucose-sensitive Neurone in the Rat Lateral Hypothalamus
OOMURA, Y., OOYAMA, H., SUGIMORI, M., NAKAMURA, T., & YAMADA, Y. (1974) · Nature · doi:10.1038/247284a0 · Cited by 358
Cited by
Cornier, M.-A., Dabelea, D., Hernandez, T. L., Lindstrom, R. C., Steig, A. J., Stob, N. R., Van Pelt, R. E., Wang, H., & Eckel, R. H. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0024 · Cited by 2,162
Vasopressin: Behavioral roles of an “original” neuropeptide
Caldwell, H. K., Lee, H.-J., Macbeth, A. H., & Young, W. S. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.10.007 · Cited by 504
“, 2006) and impaired lipid metabolism and glucose homeostasis (Aoyagi et al., 2007; Hiroyama et al., 2007).”
BackgroundVasopressin V1a and V1b Receptors: From Molecules to Physiological Systems
Koshimizu, T.-A., Nakamura, K., Egashira, N., Hiroyama, M., Nonoguchi, H., & Tanoue, A. (2012) · Physiological Reviews · doi:10.1152/physrev.00035.2011 · Cited by 407
“Because V1aR-KO mice are glucose intolerant and resistant to insulin-mediated glucose uptake (26), it can be speculated that the hypermetabolism of fat is a compensatory mechanism for the reduced capacity to use glucose as an energy source.”
BackgroundMethodResultInfluentialSelf-citationPlasma Copeptin and the Risk of Diabetes Mellitus
Enhörning, S., Wang, T. J., Nilsson, P. M., Almgren, P., Hedblad, B., Berglund, G., Struck, J., Morgenthaler, N. G., Bergmann, A., Lindholm, E., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.909663 · Cited by 299
Kohno, D., Nakata, M., Maejima, Y., Shimizu, H., Sedbazar, U., Yoshida, N., Dezaki, K., Onaka, T., Mori, M., & Yada, T. (2008) · Endocrinology · doi:10.1210/en.2007-1276 · Cited by 258
Vasopressin: a novel target for the prevention and retardation of kidney disease?
Bankir, L., Bouby, N., & Ritz, E. (2013) · Nature Reviews Nephrology · doi:10.1038/nrneph.2013.22 · Cited by 214
Enhörning, S., Bankir, L., Bouby, N., Struck, J., Hedblad, B., Persson, M., Morgenthaler, N. G., Nilsson, P. M., & Melander, O. (2013) · International Journal of Obesity · doi:10.1038/ijo.2012.88 · Cited by 192
Plasma Copeptin, A Unifying Factor behind the Metabolic Syndrome
Enhörning, S., Struck, J., Wirfält, E., Hedblad, B., Morgenthaler, N. G., & Melander, O. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2981 · Cited by 177
Hypothalamic control of energy metabolism via the autonomic nervous system
Kalsbeek, A., Bruinstroop, E., Yi, C. X., Klieverik, L. P., La Fleur, S. E., & Fliers, E. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05800.x · Cited by 148
Blevins, J. E., & Baskin, D. G. (2015) · Physiology & Behavior · doi:10.1016/j.physbeh.2015.05.023 · Cited by 134
Szczepanska‐Sadowska, E. K., Cudnoch‐Jędrzejewska, A., Ufnal, M., & Żera, T. (2010) · PubMed · Cited by 130
Light modulates glucose metabolism by a retina-hypothalamus-brown adipose tissue axis
Meng, J.-J., Shen, J., Li, G., Ouyang, C., Hu, J., Li, Z., Zhao, H., Shi, Y., Zhang, M., Liu, R., et al. (2023) · Cell · doi:10.1016/j.cell.2022.12.024 · Cited by 126
Nature, nurture and epigenetics
Crews, D., Gillette, R., Miller-Crews, I., Gore, A. C., & Skinner, M. K. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.07.013 · Cited by 116
“In the vinclozolin lineage, regardless of CRS exposure, arginine vasopressin peptide (Avp) is affected in the male lateral hypothalamus; arginine vasopressin is released to the lateral hypothalamus and is suspected to be involved in the control water and food intake and anxiety-related behaviors (Aoyagi et al., 2007;…”
Vasopressin regulation of blood pressure and volume: findings from V1a receptor–deficient mice
Aoyagi, T., Koshimizu, T., & Tanoue, A. (2009) · Kidney International · doi:10.1038/ki.2009.319 · Cited by 94
Self-citationAoyagi, T., Izumi, Y., Hiroyama, M., Matsuzaki, T., Yasuoka, Y., Sanbe, A., Miyazaki, H., Fujiwara, Y., Nakayama, Y., Kohda, Y., et al. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00088.2008 · Cited by 93
Self-citationAn atlas of G-protein coupled receptor expression and function in human subcutaneous adipose tissue
Amisten, S., Neville, M. J., Hawkes, R. G., Persaud, S. J., Karpe, F., & Salehi, A. A. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.09.007 · Cited by 92
Abbasi, A., Corpeleijn, E., Meijer, E., Postmus, D., Gansevoort, R. T., Gans, R. O. B., Struck, J., Hillege, H. L., Stolk, R. P., Navis, G., et al. (2012) · Diabetologia · doi:10.1007/s00125-012-2545-x · Cited by 90
“The arginine vasopressin (AVP) stress-adaptation system has been shown to play a role in glucose homeostasis in both experimental and human studies [1, 2].”
BackgroundBenrick, A., Schéle, E., Pinnock, S. B., Wernstedt‐Asterholm, I., Dickson, S. L., Karlsson‐Lindahl, L., & Jansson, J. ‐. (2009) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2009.01879.x · Cited by 79
Taveau, C., Chollet, C., Waeckel, L., Desposito, D., Bichet, D. G., Arthus, M.-F., Magnan, C., Philippe, E., Paradis, V., Foufelle, F., et al. (2015) · Diabetologia · doi:10.1007/s00125-015-3496-9 · Cited by 86
“V1aR-knockout and V1bR (alias Avpr1b)-knockout mice exhibited the opposite phenotype concerning insulin sensitivity [12, 13], but the contribution of VP to glucose metabolism seems greater through V1aR than through V1bR.”
Arginine vasopressin infusion is sufficient to model clinical features of preeclampsia in mice
Sandgren, J. A., Deng, G., Linggonegoro, D. W., Scroggins, S. M., Perschbacher, K. J., Nair, A. R., Nishimura, T. E., Zhang, S. Y., Agbor, L. N., Wu, J., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.99403 · Cited by 80
Arginine vasopressin: Direct and indirect action on metabolism
Yoshimura, M., Conway-Campbell, B. L., & Ueta, Y. (2021) · Peptides · doi:10.1016/j.peptides.2021.170555 · Cited by 79
Plasma Copeptin, AVP Gene Variants, and Incidence of Type 2 Diabetes in a Cohort From the Community
Roussel, R., Boustany, R. E., Bouby, N., Potier, L., Fumeron, F., Mohammedi, K., Balkau, B., Tichet, J., Bankir, L., Marre, M., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1113 · Cited by 78
“insulin resistance, and impaired glucose tolerance (8).”
Insulin hypersensitivity in mice lacking the V1b vasopressin receptor
Fujiwara, Y., Hiroyama, M., Sanbe, A., Aoyagi, T., Birumachi, J., Yamauchi, J., Tsujimoto, G., & Tanoue, A. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2007.136481 · Cited by 75
“…584.1 Insulin hypersensitivity in V1bR−/− mice 237 2 days before the experiments, 10-week-old mice were anaesthetized with sodium pentobarbital (40 mg kg−1, i.p.), and an indwelling catheter was inserted in the left jugular vein as described in previously (Tanoue et al. 2002; Aoyagi et al. 2007).”
MethodSelf-citationImproving Metabolic Health Through Precision Dietetics in Mice
Barrington, W. T., Wulfridge, P., Wells, A. E., Rojas, C. M., Howe, S. Y. F., Perry, A., Hua, K., Pellizzon, M. A., Hansen, K. D., Voy, B. H., et al. (2018) · Genetics · doi:10.1534/genetics.117.300536 · Cited by 67
“The phenotypic changes observed in B6 mice fed the American diet are consistent with those of Avpr1a knockout mice (Aoyagi et al. 2007).”
BackgroundVasopressin and metabolic disorders: translation from experimental models to clinical use
Nakamura, K., Velho, G., & Bouby, N. (2017) · Journal of Internal Medicine · doi:10.1111/joim.12649 · Cited by 63
Genetic vasopressin 1b receptor variance in overweight and diabetes mellitus
Enhörning, S., Sjögren, M., Hedblad, B., Nilsson, P. M., Struck, J., & Melander, O. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-0781 · Cited by 62
Relation between human vasopressin 1a gene variance, fat intake, and diabetes
Enhörning, S., Leosdottir, M., Wallström, P., Gullberg, B., Berglund, G., Wirfält, E., & Melander, O. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26382 · Cited by 55
Arginine vasopressin receptor signaling and functional outcomes in heart failure
Wasilewski, M. A., Myers, V. D., Recchia, F. A., Feldman, A. M., & Tilley, D. G. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.07.021 · Cited by 53
“Additionally, studies using V1AR knockout mice and isolated cells showed that the V1AR regulates glucose homeostasis [39], mediates the release of aldosterone from adrenal gland cells [38, 40], controls social interactions [41], and platelet”
Izumi, Y., Hori, K., Nakayama, Y., Kimura, M., Hasuike, Y., Nanami, M., Kohda, Y., Otaki, Y., Kuragano, T., Obinata, M., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010050468 · Cited by 47
Self-citationCopeptin in obese children and adolescents: relationships to body mass index, cortisol and gender
Rothermel, J., Kulle, A. E., Holterhus, P., Toschke, C., Lass, N., & Reinehr, T. (2016) · Clinical Endocrinology · doi:10.1111/cen.13235 · Cited by 47
Oxytocin Receptor Signaling in Vascular Function and Stroke
McKay, E. C., & Counts, S. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.574499 · Cited by 46
“Another option is, again, the observed prosurvival and glucose metabolism supporting effects as evidenced by vasopressin administration and V1aR knockout animals (Aoyagi et al., 2007; Ghorbanzadeh et al., 2020).”
BackgroundSensory Circumventricular Organs, Neuroendocrine Control, and Metabolic Regulation
Jeong, J. K., Dow, S. A., & Young, C. N. (2021) · Metabolites · doi:10.3390/metabo11080494 · Cited by 45
Both V1A and V1B vasopressin receptors deficiency result in impaired glucose tolerance
Nakamura, K., Aoyagi, T., Hiroyama, M., Kusakawa, S., Mizutani, R., Sanbe, A., Yamauchi, J., Kamohara, M., Momose, K., & Tanoue, A. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.04.008 · Cited by 41
Self-citationAoyagi, T., Higa, J. K., Aoyagi, H., Yorichika, N., Shimada, B. K., & Matsui, T. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00008.2015 · Cited by 40
“To evaluate HFD-induced glucose intolerance and insulin resistance, we performed glucose tolerance tests (GTTs) and insulin tolerance tests (ITTs) after 12 wk of NCD or HFD feeding as previously demonstrated (4, 36).”
MethodSelf-citationAcute and chronic hyperglycemic effects of vasopressin in normal rats: involvement of V1Areceptors
Taveau, C., Chollet, C., Bichet, D. G., Velho, G., Guillon, G., Corbani, M., Roussel, R., Bankir, L., Melander, O., & Bouby, N. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00269.2016 · Cited by 40
“Mice with genetic inactivation of either V1AR or V1BR display opposite phenotypes with either higher or lower fasting glycemia, respectively, than wild type (3, 18).”
BackgroundOxytocin and Vasopressin Systems in Obesity and Metabolic Health: Mechanisms and Perspectives
Ding, C., & Magkos, F. (2019) · Current Obesity Reports · doi:10.1007/s13679-019-00355-z · Cited by 40
Enhanced effect of neuropeptide Y on food intake caused by blockade of the V1A vasopressin receptor
Aoyagi, T., Kusakawa, S., Sanbe, A., Hiroyama, M., Fujiwara, Y., Yamauchi, J., & Tanoue, A. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.09.017 · Cited by 38
Self-citationThen, C., Kowall, B., Lechner, A., Meisinger, C., Heier, M., Köenig, W., Peters, A., Rathmann, W., & Seißler, J. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0609-8 · Cited by 37
A Journey through the Early Evidence Linking Hydration to Metabolic Health
Vanhaecke, T., Perrier, E. T., & Melander, O. (2020) · Annals of Nutrition and Metabolism · doi:10.1159/000515021 · Cited by 37
Altered lipid metabolism in vasopressin V receptor-deficient mice
Hiroyama, M., Fujiwara, Y., Nakamura, K., Aoyagi, T., Mizutani, R., Sanbe, A., Tasaki, R., & Tanoue, A. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.11.043 · Cited by 37
“V 1A R −/− mice exhibit the hypermetabolism of fat and muscular protein, and insulin resistance (Aoyagi et al., 2007; Hiroyama et al., 2007a,b).”
BackgroundSelf-citationNoor, T., Hanif, F. M., Kiran, Z., Rehman, R., Khan, M. T., Haque, Z., & Nankani, K. (2020) · Archives of Medical Research · doi:10.1016/j.arcmed.2020.05.018 · Cited by 36
Masuki, S., Mori, M., Tabara, Y., Miki, T., Sakurai, A., Morikawa, M., Miyagawa, K., Higuchi, K., & Nosé, H. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.147728 · Cited by 31
Yi, S. S., Hwang, I. K., Kim, Y. N., Kim, I. Y., Pak, S.-I., Lee, I. S., Seong, J. K., & Yoon, Y. S. (2008) · Neurochemical Research · doi:10.1007/s11064-007-9519-2 · Cited by 30
“The phenotype of V1a receptor knocked out (V1aR ) mice was consistent with clinical data from a type 2 diabetes patient [33], who showed impaired glucose tolerance and intact insulin secretion [34].”
MethodBarchetta, I., Enhörning, S., Cimini, F. A., Capoccia, D., Chiappetta, C., Cristofano, C. D., Silecchia, G., Leonetti, F., Melander, O., & Cavallo, M. G. (2019) · BMC Medicine · doi:10.1186/s12916-019-1319-4 · Cited by 30
Fujiwara, Y., Tanoue, A., Tsujimoto, G., & Koshimizu, T. (2011) · Clinical and Experimental Nephrology · doi:10.1007/s10157-011-0497-y · Cited by 30
“Although the primary mechanisms underlying the reduction in blood volume remain unclear, a decrease in circulating aldosterone levels and low responsiveness to corticosterone secretion upon adrenocortical hormone stimulation could be involved in blood volume reduction in V1a mice [23, 25, 26].”
BackgroundSelf-citationAutonomic Regulation of Hepatic Glucose Production
Bisschop, P. H. L. T., Fliers, E., & Kalsbeek, A. (2014) · Comprehensive physiology · doi:10.1002/cphy.c140009 · Cited by 29
Vasopressin Receptor Antagonists
Palmer, B. F. (2015) · Current Hypertension Reports · doi:10.1007/s11906-014-0510-4 · Cited by 29
Zhu, F., Wu, H., Tu, K.-S., Chen, J., Zhang, M., & Shi, C. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.07.017 · Cited by 30
Effect of acute hypohydration on glycemic regulation in healthy adults: a randomized crossover trial
Carroll, H. A., Templeman, I., Chen, Y., Edinburgh, R. M., Burch, E. K., Jewitt, J. T., Povey, G., Robinson, T. D., Dooley, W. L., Jones, R., et al. (2018) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00771.2018 · Cited by 28
“Specifically, V1aR / mice have reduced adipose tissue glucose tolerance, whereas V1bR / mice have increased adipose tissue insulin sensitivity (1, 14, 28).”
BackgroundEnhanced glucose tolerance in the Brattleboro rat
Nakamura, K., Yamashita, T., Fujiki, H., Aoyagi, T., Yamauchi, J., Mori, T., & Tanoue, A. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.12.126 · Cited by 28
Self-citationBirumachi, J., Hiroyama, M., Fujiwara, Y., Aoyagi, T., Sanbe, A., & Tanoue, A. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.03.022 · Cited by 28
Self-citationElucidating the mechanisms by which disulfiram protects against obesity and metabolic syndrome
Bernier, M., Harney, D., Koay, Y. C., Diaz, A., Singh, A., Wahl, D., Pulpitel, T., Ali, A., Guiterrez, V., Mitchell, S. J., et al. (2020) · npj Aging and Mechanisms of Disease · doi:10.1038/s41514-020-0046-6 · Cited by 26
Dabrowski, F. A., Jarmużek, P., Gondek, A., Cudnoch‐Jędrzejewska, A., Bomba-Opon, D. A., & Wielgoś, M. (2016) · Ginekologia Polska · doi:10.5603/gp.2016.0057 · Cited by 24
“In an animal study, elevated AVP level as a result of AVP resistance at the level of V1aR was related to insulin resistance and diabetes mellitus [22, 23].”
BackgroundVillela-Torres, M. D. L. L., Higareda-Mendoza, A. E., Gómez‐García, A., Paredes, A. R. Á., García‐López, E., Stenvikel, P., Gu, H. F., Rashid-Qureshi, A., Lindholm, B., & Álvarez-Aguilar, C. (2018) · Archives of Medical Research · doi:10.1016/j.arcmed.2018.04.002 · Cited by 23
Disorders of the Posterior Pituitary
Srivatsa, A., & Majzoub, J. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-62520-3.00012-9 · Cited by 23
Hiroyama, M., Aoyagi, T., Fujiwara, Y., Oshikawa, S., Sanbe, A., Endo, F., & Tanoue, A. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2007.129569 · Cited by 22
“In addition, the food intake of V1aR−/− mice was smaller than that of V1aR+/+ mice (Aoyagi et al. 2007).”
BackgroundResultInfluentialSelf-citationClass A and C GPCR Dimers in Neurodegenerative Diseases
Moreira, I. S., Caniceiro, A. B., Bueschbell, B., & Schiedel, A. C. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220327221830 · Cited by 20
Suprachiasmatic Nucleus Neuropeptides and Their Control of Endogenous Glucose Production
Foppen, E., Tan, A. A. T., Ackermans, M. T., Fliers, E., & Kalsbeek, A. (2016) · Journal of Neuroendocrinology · doi:10.1111/jne.12365 · Cited by 20
Water intake keeps type 2 diabetes away? Focus on copeptin
Muscogiuri, G., Barrea, L., Annunziata, G., Vecchiarini, M., Orio, F., Somma, C. D., Colao, A., & Savastano, S. (2018) · Endocrine · doi:10.1007/s12020-018-1680-7 · Cited by 20
Tanoue, A. (2009) · Journal of Pharmacological Sciences · doi:10.1254/jphs.08r15fm · Cited by 20
Self-citationArginine vasopressin inhibits adipogenesis in human adipose-derived stem cells
Tran, T. D. N., Yao, S., Hsu, W. H., Gimble, J. M., Bunnell, B. A., & Cheng, H. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.02.009 · Cited by 19
“Studies in V1a receptor knockout mice show enhanced lipid metabolism, muscle proteolysis and insulin signaling suppression that is supported by observations of impaired glucose tolerance in these animals (Aoyagi et al., 2007; Hiroyama et al., 2007; Nakamura et al., 2009).”
BackgroundRegulation of V2R transcription by hypertonicity and V1aR-V2R signal interaction
Izumi, Y., Nakayama, Y., Memetimin, H., Inoue, T., Kohda, Y., Nonoguchi, H., & Tomita, K. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00119.2008 · Cited by 17
Perinatal Lack of Maternal IL-6 Promotes Increased Adiposity During Adulthood in Mice
Lager, S., Asterholm, I. W., Schéle, E., Jansson, N., Nilsson, S., Jansson, J., Lönn, M., & Holmäng, A. B. (2011) · Endocrinology · doi:10.1210/en.2010-0921 · Cited by 16
Melchers, M., de Smet, V., Rooijakkers, C., Huising, J., Vermeulen, W., Köktaş, B. N. N., van de Vusse, K. J., Sabzewar, K. M., Mishra, S. B., Bethlehem, C., et al. (2025) · Annals of Intensive Care · doi:10.1186/s13613-025-01472-w · Cited by 15
“V1aR knockout models, which lack the receptor on which AVP exerts its vasoconstric-tive abilities, are prone to obesity [35].”
Is copeptin a new potential biomarker of insulin resistance in polycystic ovary syndrome?
Widecka, J., Ożegowska, K., Banaszewska, B., Kazienko, A., Safranow, K., Branecka-Woźniak, D., Pawelczyk, L. A., & Kurzawa, R. (2019) · Ginekologia Polska · doi:10.5603/gp.2019.0021 · Cited by 14
“Research on an animal model involving mice lacking V1aR showed display-impaired glucose tolerance and development of IR with increased AVP levels, whereas mice that lacked V1bR had lower fasting plasma glucose level and increased insulin sensitivity [22, 23].”
Vasopressin V1a receptor is required for nucleocytoplasmic transport of mineralocorticoid receptor
Hori, K., Nagai, T., Izumi, Y., Kimura, M., Hasuike, Y., Nakayama, Y., Nanami, M., Tokuyama, M., Otaki, Y., Kuragano, T., et al. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00052.2012 · Cited by 14
Self-citationNeural Substrates Underlying Interactions between Appetite Stress and Reward
Menzies, J. R. W., Skibicka, K. P., Dickson, S. L., & Leng, G. (2012) · Obesity Facts · doi:10.1159/000338237 · Cited by 14
Metabolic effects of vasopressin in pathophysiology of diabetic kidney disease
Lebedeva, S. A., Margaryan, A. G., Smolyarchuk, Е. А., Nedorubov, A. A., Materenchuk, M. Y., Tonevitsky, A., & Mutig, K. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1176199 · Cited by 13
Vasopressin as Possible Treatment Option in Autism Spectrum Disorder
László, K., Vörös, D., Correia, P., Fazekas, C. L., Török, B., Plangár, I., & Zelena, D. (2023) · Biomedicines · doi:10.3390/biomedicines11102603 · Cited by 13
Rethinking Vasopressin: New Insights into Vasopressin Signaling and Its Implications
Watts, J. A., & Arroyo, J. P. (2023) · Kidney360 · doi:10.34067/kid.0000000000000194 · Cited by 12
Elevated plasma levels of copeptin linked to diabetic retinopathy in type 2 diabetes
Zhao, Q., Wu, X.-X., Zhou, J., & Wang, X. D. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.12.003 · Cited by 12
Delaying time to first nocturnal void may have beneficial effects on reducing blood glucose levels
Juul, K. V., Jessen, N., Bliwise, D. L., van der Meulen, E., & Nørgaard, J. P. (2016) · Endocrine · doi:10.1007/s12020-016-0920-y · Cited by 12
Szczepanska‐Sadowska, E. K., Cudnoch‐Jędrzejewska, A., & Żera, T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413307 · Cited by 11
“Subsequently, experiments using the hyperinsulinemic-euglycemic clamp model revealed that V1aR-deficient rats are less sensitive to insulin, whereas V1bR-deficient mice maintained on a high-fat diet manifest impaired glucose tolerance and develop overt obesity [71,161,162].”
Szczepanska‐Sadowska, E. K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021310 · Cited by 11
Peripheral Signals Modifying Food Reward
Menzies, J. R. W., Skibicka, K. P., Egecioglu, E., Leng, G., & Dickson, S. L. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-24716-3_6 · Cited by 11
Disorders of the posterior pituitary
Muglia, L. J., Srivatsa, A., & Majzoub, J. A. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-4858-7.00020-2 · Cited by 11
Harada, K., Wada, E., Osuga, Y., Shimizu, K., Uenoyama, R., Hirai, M. Y., Maekawa, F., Miyazaki, M., Hayashi, Y. K., Nakamura, K., et al. (2024) · Molecular Metabolism · doi:10.1016/j.molmet.2024.102072 · Cited by 9
Vasopressin and oxytocin receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database
Bichet, D. G., Bouvier, M., Chini, B., Gimpl, G., Guillon, G., Kimura, T., Knepper, M. A., Lolait, S. J., Manning, M., Mouillac, B., et al. (2019) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f66/2019.4 · Cited by 9
Critical role of V1a vasopressin receptor in murine parturition†
Tsuchiya, H., Fujimura, S., Fujiwara, Y., & Koshimizu, T. (2019) · Biology of Reproduction · doi:10.1093/biolre/ioz220 · Cited by 9
“In Avpr1a-deficient mice, plasma aldosterone levels are significantly reduced [32].”
BackgroundSelf-citationKoceva, A., Janež, A., & Jensterle, M. (2025) · Medicina · doi:10.3390/medicina61050838 · Cited by 8
“V1aR-deficient mice also have decreased levels of aldosterone, which decreases plasma volume and may also exacerbate hyperglycemia [18].”
InfluentialVasopressin-induced Ca2+ signals in human adipose-derived stem cells
Tran, T. D. N., Gimble, J. M., & Cheng, H. (2016) · Cell Calcium · doi:10.1016/j.ceca.2015.12.006 · Cited by 8
“reduced aldosterone level and fatty liver [64].”
BackgroundHydration for Health: So What? Ten Advances in Recent Hydration History
Perrier, E. T. (2019) · Annals of Nutrition and Metabolism · doi:10.1159/000500343 · Cited by 8
Haider, A., Xiao, Z., Xia, X., Chen, J., Van, R. S., Kuang, S., Zhao, C., Rong, J., Shao, T., Ramesh, P., et al. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105886 · Cited by 7
Effects of central gastrin-releasing peptide on glucose metabolism
Jha, P. K., Foppen, E., Challet, É., & Kalsbeek, A. (2015) · Brain Research · doi:10.1016/j.brainres.2015.08.040 · Cited by 7
Mohan, S., Flatt, P. R., Irwin, N., & Moffett, R. C. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14462 · Cited by 7
“Although it has been suggested that the stimulatory effects of AVP on insulin secretion are indirectly mediated by glucagon via paracrine islet interactions,(20) we and others clearly show involvement of direct beta-cell stimulatory effects.(12,18,39) In agreement, we observed only moderate insulinotropic actions of t…”
ResultMelchers, M., Pickkers, P., & van Zanten, A. R. H. (2026) · Critical Care · doi:10.1186/s13054-026-05871-8 · Cited by 6
Goparaju, P., & Gragnoli, C. (2024) · Journal of Ovarian Research · doi:10.1186/s13048-024-01515-z · Cited by 5
“The latter finding is consistent with the fact that concomitant knock-out of the two receptors in mice and rats causes impaired glucose tolerance [20, 21].”
ResultKim, D. H., Kim, K. K., Lee, T. H., Eom, H., Kim, J. W., Park, J. W., Jeong, J. K., & Lee, B. J. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.627343 · Cited by 5
“For example, AVP resistance, a chronic elevation in plasma AVP levels and decreased responsiveness of AVP receptors, is a leading factor in the development of obesity caused by increased food intake and impaired glucose metabolism (24).”
BackgroundVasopressin V1a receptor and oxytocin receptor regulate murine sperm motility differently
Tsuchiya, H., Fujinoki, M., Azuma, M., & Koshimizu, T. (2023) · Life Science Alliance · doi:10.26508/lsa.202201488 · Cited by 4
“However, consistent with the findings of a previous study (Aoyagi et al, 2007), our observations revealed that the body weights of the V1a-deficient mice were lower than those of WT (WT: 31.5 ± 0.9 g, V1adeficient: 24.7 ± 0.8 g, P 0.001, n = 8).”
BackgroundResultInfluentialCarroll, H. A., Ericson, U., Ottosson, F. A., Enhörning, S., & Melander, O. (2024) · PLoS ONE · doi:10.1371/journal.pone.0296778 · Cited by 4
Tregeagle, D. F. L., Doherty, C., Callis, T. B., & Kassiou, M. (2025) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2025.04.004 · Cited by 3
Mohan, S., Lafferty, R. A., Flatt, P. R., Moffett, R. C., & Irwin, N. (2022) · Peptides · doi:10.1016/j.peptides.2022.170772 · Cited by 3
Vasopressin and oxytocin receptors in GtoPdb v.2023.1
Bichet, D. G., Bouvier, M., Chini, B., Gimpl, G., Guillon, G., Kimura, T., Knepper, M. A., Lolait, S. J., Manning, M., Mouillac, B., et al. (2023) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f66/2023.1 · Cited by 3
Verbalis, J. G. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00049-8 · Cited by 3
THE VASOPRESSIN SYSTEM IN DIABETES MELLITUS, OBESITY AND THE METABOLIC SYNDROME
Enhörning, S. (2012) · Lund University Publications (Lund University) · Cited by 3
El-Shaarawy, A. M., Marei, T. A., & Elbatanony, H. M. (2017) · The Egyptian Journal of Cardiothoracic Anesthesia · doi:10.4103/ejca.ejca_15_17 · Cited by 2
Effect of Pituitary-Target Gland Axis on RAAS in the Context of COVID-19
Wu, B., Li, R., Liu, Q., Jin, S., Wei, H., Xu, M., Zhang, Y., & Liu, Y. (2025) · International Journal of Medical Sciences · doi:10.7150/ijms.114924 · Cited by 1
“It also mediates cell proliferation, platelet aggregation, glycogenolysis, and lipid metabolism [106, 107].”
Vasopressin and oxytocin receptors in GtoPdb v.2025.3
Bichet, D. G., Wheatley, M., Verbalis, J. G., Soloff, M. S., Gal, C. S., O'Carroll, A.-M., Mouillac, B., Manning, M., Lolait, S. J., Knepper, M., et al. (2025) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f66/2025.3 · Cited by 1
Persistent prostaglandin E2 upregulation and hormonal multi-resistance: A hypothesis for long COVID
Ramer, V., & van Montfrans, G. A. (2026) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2026.102518 · Cited by 1
“From an evolutionary perspective, a heightened form of multiple hormonal resistance may have been advantageous in contexts such as hibernation, where resistance to leptin, AVP [69] and insulin supports hyperphagia, elevated glucose levels, and fat accumulation.”
Arginine vasopressin: A promising therapeutic target for metabolic syndrome
Elsamad, G., Alotaibi, M. I., Echtay, K. S., Murphy, D., & Greenwood, M. P. (2026) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/j.jpet.2026.104936 · Cited by 1
Metadata
- Authors
- Aoyagi, T., Birumachi, J.-I., Hiroyama, M., Fujiwara, Y., Sanbe, A., Yamauchi, J., & Tanoue, A.
- Affiliations
- National Research Institute for Child Health and Development (JP)
- Corresponding author
- Tanoue, Akito
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2007-05-01
- Volume
- 148
- Issue
- 5
- Pages
- 2075-2084
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W1964228140
- Semantic Scholar
- f9abd80b89e1d27908cc1c182452cb2cd575de1d
- Cited by
- 113
- References
- 53
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 5 · 2023: 5 · 2022: 5 · 2021: 6 · 2020: 5 · 2019: 7 · 2018: 4 · 2017: 4 · 2016: 11 · 2015: 9 · 2014: 5 · 2013: 2 · 2012: 6
- FWCI
- 7.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Nephrology › Electrolyte and hormonal disorders
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- vasopressin V1a receptor, vasopressin, glucose homeostasis, glucose tolerance, hepatic glucose production, liver glycogen, plasma volume, aldosterone, obesity, high-fat diet, insulin signaling, type 2 diabetes
- MeSH terms
- Animals, Arginine Vasopressin, Blood Glucose, Body Weight, Energy Intake, Dietary Fats, Feeding Behavior, Glycogen, Homeostasis, Insulin, Liver, Male, Mice, Inbred C57BL, Mice, Mutant Strains, Obesity, Plasma Volume, Receptors, Vasopressin, Leptin, Metabolic Syndrome, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.